The Future of Pain Management and Research: A Dose of Fatalism May Be Good for One's Health
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
My formula for greatness in a human being is ‘amor fati’: that one wants nothing to be different, not forward, not backward, not in all eternity. Not merely bear what is necessary, still less conceal it…but love it. —Friedrich Nietzsche The views on chronic pain expressed herein are those of a general neurologist with a skeptical turn of mind, who has practiced for 27 years at a large county hospital in the heart of Silicon Valley. While these views have a pessimistic aspect, I want to propose that new goals and new hopes often arise like a phoenix from the ashes of pessimism. Nietzsche’s philosophy likewise comprised a pessimistic element, but unlike the pessimism of Schopenhauer, Nietzsche’s pessimism was life-affirming. There still could be an altogether different kind of pessimism.… I call this pessimism of the future—for it comes! I see it coming! —Friedrich Nietzsche, on Dionysian pessimism, from The Gay Science Indeed, Nietzsche valued growth and self-overcoming above all else, and these life-affirming values, by definition, require opposing forces—namely, the pain and suffering of human existence, without which there can be no joy, no beauty, in self-overcoming. And life confided the secret to me: Behold, it said, I am that which must always overcome itself. —Friedrich Nietzsche, from Thus Spoke Zarathustra In the spirit of Dionysian pessimism, I would like to try to answer two questions: What are the reasons for pessimism with respect to the treatment of chronic pain? and By what means can patients, and their providers, subjugate this pessimism and engage in life-affirming growth and self-overcoming? For the purposes of this article, I will focus primarily on low back pain and sciatica, but the concerns raised herein apply to all forms of chronic pain seen in our neurology clinic. When management of back pain and sciatica fails to achieve satisfactory results, as is too often the case, the repeated frustration and disappointment are rendered all the more profound by the unrealistic expectations created by the medical–industrial complex in promoting various pharmacologic and invasive treatments. Data supporting medications and invasive interventions for back pain and sciatica are far from robust [1–4]. Moreover, the published reports of positive, “statistically significant” results in treatment trials continue to invite skeptical interpretation because of publication bias and other confounding factors [5]. Not least among these confounding factors is the influence of the drug and device manufacturers that sponsor the research, including their influence on study design [6]. Finally, we must remember that the concept of “statistical significance” has an inherently arbitrary aspect and that, in any case, statistical significance does not equal clinical significance. In spite of these caveats, low-value treatments continue to be overused, not just in the United States, but around the world [3]. Notwithstanding this sober assessment of pharmacologic and invasive treatments for low back pain and sciatica, the general public and the majority of practicing physicians have fallen victim to the overstated, sometimes fraudulent, claims of certain medical–industrial institutions. As the most obvious example, the role of the pharmaceutical industry in promoting the widespread overuse of opiates in the treatment of pain is well documented [7]. Along the same vein, we must recall the history of gabapentin, which initially was highly touted as a treatment for painful diabetic polyneuropathy. Pfizer, the maker of gabapentin, paid a $325M settlement for promoting the drug for off-label usages, despite the lack of scientific evidence. Nevertheless, that $325M investment has paid huge dividends: gabapentin remains by far the most commonly prescribed drug for a whole host of chronic pain problems, many of them ill-defined but often labeled as “neuropathic” to justify opening the special medicine cabinet reserved for this dreaded category of chronic pain. Based on published and unpublished studies, gabapentin’s role in treating painful diabetic polyneuropathy and chronic low back pain is dubious at best [8,9]. Likewise, its cousin, pregabalin, now appears largely ineffective for radicular pain [10]. In short, patients have been conditioned by our culture to expect too much from modern medicine. To quote Rudy Waltz, the narrator in Kurt Vonnegut’s “Deadeye Dick,” describing a local doctor in fictional Midland City, Ohio: “Dr. Mitchell was building a big practice on the principle that nobody in modern times should ever be the least uncomfortable or dissatisfied, since there were now pills for everything.” Unfortunately, front-line practitioners, caught between ingenuous patients and an often disingenuous medical–industrial complex, find it very difficult to offer a more honest perspective, even as this perspective is now substantiated in widely published guidelines. The truth can be very disappointing, and doctors do not w
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702
Prevention and treatment of low back pain: evidence, challenges, and promising directions
Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., Ferreira, P. H., Fritz, J. M., Koes, B. W., Peul, W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30489-6 · Cited by 2,398
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
Overtreating chronic back pain: time to back off?
Deyo, R. A., Mirza, S. K., Turner, J. A., & Martin, B. I. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.01.080102 · Cited by 796
Veehof, M. M., Trompetter, H. R., Bohlmeijer, E. T., & Schreurs, K. M. G. (2016) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1098724 · Cited by 737
Acceptance and Commitment Therapy (ACT) for Chronic Pain: A Systematic Review and Meta-Analyses
Hughes, L. S., Clark, J., Colclough, J. A., Dale, E., & McMillan, D. (2017) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000425 · Cited by 611
Hann, K. E. J., & McCracken, L. M. (2014) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2014.10.001 · Cited by 259
The Placebo Effect: Illness and Interpersonal Healing
Miller, F. G., Colloca, L., & Kaptchuk, T. J. (2009) · Perspectives in Biology and Medicine · doi:10.1353/pbm.0.0115 · Cited by 254
Trial of pregabalin for acute and chronic sciatica
Mathieson, S., Maher, C. G., McLachlan, A. J., Latimer, J., Koes, B. W., Hancock, M. J., Harris, I., Day, R. O., Billot, L., Pik, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614292 · Cited by 219
Schu, S., Slotty, P. J., Bara, G., von Knop, M., Edgar, D., & Vesper, J. (2014) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12197 · Cited by 206
Chou, R., Hashimoto, R., Friedly, J., Fu, R., Bougatsos, C., Dana, T., Sullivan, S. D., & Jarvik, J. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0934 · Cited by 200
Current status of acceptance and commitment therapy for chronic pain: A narrative review
Feliu Soler, A., Montesinos, F., Gutiérrez-Martínez, O., Scott, W., McCracken, L., & Luciano, J. (2018) · Journal of Pain Research · doi:10.2147/jpr.s144631 · Cited by 198
Perceived Injustice: A Risk Factor for Problematic Pain Outcomes
Sullivan, M. J. L., Scott, W., & Trost, Z. (2012) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3182527d13 · Cited by 187
Perruchoud, C., Eldabe, S., Batterham, A. M., Madzinga, G., Brookes, M., Durrer, A., Rosato, M., Bovet, N., West, S., Bovy, M., et al. (2013) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12027 · Cited by 177
Shanthanna, H., Gilron, I., Rajarathinam, M., AlAmri, R., Kamath, S., Thabane, L., Devereaux, P. J., & Bhandari, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002369 · Cited by 177
Thomson, S. J., Tavakkolizadeh, M., Love-Jones, S., Patel, N. K., Gu, J. W., Bains, A., Doan, Q., & Moffitt, M. (2018) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12746 · Cited by 172
Schaefer, M., Sahin, T., & Berstecher, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192758 · Cited by 136
Al-Kaisy, A. A., Palmisani, S., Pang, D. C., Sanderson, K., Wesley, S., Tan, Y., McCammon, S., & Trescot, A. M. (2018) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12771 · Cited by 129
Placebos Without Deception: Outcomes, Mechanisms, and Ethics
Colloca, L., & Howick, J. (2018) · International Review of Neurobiology · doi:10.1016/bs.irn.2018.01.005 · Cited by 108
Interpreting Surgical Trials With Subjective Outcomes: Avoiding UnSPORTsmanlike Conduct
Flum, D. R. (2006) · JAMA · doi:10.1001/jama.296.20.2483 · Cited by 51
Lembke, A. (2016) · Johns Hopkins University Press eBooks · doi:10.56021/9781421421407 · Cited by 40
Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked and Why It’s So Hard to Stop
Lembke, A. (2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30057-7 · Cited by 28
Two Surgeries Do Not Always Make a Right: Spinal Cord Stimulation for Failed Back Surgery Syndrome.
Duy, P. Q., & Anderson, W. S. (2018) · PubMed Central · Cited by 12
Research works printed but not linked: 2
- Feldman, UpToDate
- Chou, UpToDate
Cited by
Vetterlein, A., Monzel, M., Richter‐Hetzer, S., Kapala, K., Geppert, J., Baki, S., & Reuter, M. (2022) · European Journal of Pain · doi:10.1002/ejp.1932 · Cited by 7
“Acceptance & stoicism This attitude means accepting and enduring pain as something outside of human control (Fraser, 2019; Wicksell & Vowles, 2015).”
Background
Metadata
- Authors
- Fraser, J. L.
- Affiliations
- Santa Clara Valley Medical Center (US)
- Corresponding author
- Fraser, Jeffrey L
- ORCID
- Fraser, Jeffrey L
- Venue
- Pain Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-19
- Volume
- 20
- Issue
- 9
- Pages
- 1647-1650
- ISSN
- 1526-2375 (ISSN-L)
- 1526-4637
- OpenAlex
- W2922860354
- Semantic Scholar
- f7cfac0ff1160a6c800076fee561df25f17075a0
- Cited by
- 1
- References
- 25
- Citations by year
- 2022: 1
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Pain Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- chronic pain, low back pain, sciatica, pessimism, self-overcoming, medical-industrial complex, publication bias, pharmaceutical industry influence, treatment expectations, patient-provider relationship, pain management, Friedrich Nietzsche, placebo effect
- MeSH terms
- Humans, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.